HALOZYME
LIVE

Serial Number

99051997

Owner

HALOZYME, INC.

Attorney

Gene K. Park

Filing Date

Feb 21, 2025

Add to watchlist:

No watchlists yet
View on USPTO

HALOZYME Trademark

Serial Number: 99051997

HALOZYME is a trademark filed by HALOZYME, INC. on February 21, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

HALOZYME, INC. (28 trademarks)

11388 Sorrento Valley Road
SAN DIEGO, CA 92121

Entity Type: 03

Trademark Details

Filing Date

February 21, 2025

Registration Date

Not Registered

Published for Opposition

November 18, 2025

Goods & Services

Providing medical information in the field of subcutaneous fluid administration; providing medical information in the field of subcutaneous delivery of a wide range of pharmaceuticals

Administration of a discount program enabling patients to obtain discounts on prescription drugs through use of a discount card provided by a copay discount program; business administration of a program enabling patients to obtain discounts on prescription drugs through a cash-pay program for uninsured and underinsured patients

Scientific research and development services for the integration of technologies, therapies, and other systems for pharmaceuticals and drug delivery systems

Insurance benefits verification and prior authorization assistance in the health industry; copay assistance programs, namely, providing financial assistance to uninsured and underinsured patients for prescription medications

Drug delivery agents in the form of liquid for subcutaneous delivery that facilitate the delivery of pharmaceutical preparations; enzymes for medical purposes, namely, for facilitating delivery of fluids or pharmaceuticals; drug delivery agents consisting of pharmaceuticals containing enzymes that facilitate delivery of fluids and a wide range of pharmaceuticals; pharmaceutical preparations for use in the treatment and prevention of metabolic conditions and disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, dermatological conditions and disorders, and for the treatment of cancer and in hydration; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in aesthetic skin treatments; Hyaluronic acid for pharmaceutical purposes, namely, recombinant human hyaluronidase formulation for use in in-vitro fertilization procedures; enzymes for medical purposes, namely, recombinant human hyaluronidase formulation for use in in-vitro fertilization procedures

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 13, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 18, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 18, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 12, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 21, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 21, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 21, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 21, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 21, 2025 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 7, 2025 GNRN
NON-FINAL ACTION E-MAILED
Aug 7, 2025 GNRT
NON-FINAL ACTION WRITTEN
Aug 7, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 30, 2025 DOCK
ASSIGNED TO EXAMINER
Jul 30, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 29, 2025 NWOS
NEW APPLICATION ENTERED
Feb 24, 2025 NWAP
APPLICATION FILING RECEIPT MAILED
Feb 21, 2025 MAFR